SCILEX HOLDING CO enters SEMNUR PHARMACEUTICALS, INC. with 201.05M shares across direct and indirect positions
This filing by SCILEX HOLDING CO establishes the baseline for all future Form 4 insider transaction reports at SEMNUR PHARMACEUTICALS, INC..
Direct Indirect
Filed: 9/23/2025ACC: 0001193125-25-213763
10% Owner
Since Sep 2025
201.05M
Baseline shares
1% direct
1.05M
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
3
Security positions
200M indirect
Non-Derivative Holdings3
Common Stock
IndirectShares owned6.25M
Common Stock
IndirectShares owned193.75M
Common Stock
DirectShares owned1.05M
Total
1.05M direct·200M indirect201.05M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.25M | Indirect |
| Common Stock | 193.75M | Indirect |
| Common Stock | 1.05M | Direct |
| Total | 201.05M | 1.05M direct·200M indirect |
Derivative Holdings0
No derivative holdings reported